NovoCure (NVCR) Insider Trading & Ownership $17.23 -0.71 (-3.96%) As of 12:01 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NovoCure (NASDAQ:NVCR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.29%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$61,749.10 Get NVCR Insider Trade Alerts Want to know when executives and insiders are buying or selling NovoCure stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NVCR Insider Buying and Selling by Quarter Remove Ads NovoCure Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/1/2024Frank X LeonardEVPSell598$15.94$9,532.12 11/1/2024Mukund ParavasthuCOOSell160$15.88$2,540.80 10/31/2024Michal Nath PuriInsiderSell810$15.79$12,789.90 8/2/2024Ashley CordovaCFOSell688$20.14$13,856.32 6/4/2024W Anthony VernonDirectorSell964$23.89$23,029.96 (Data available from 1/1/2013 forward) NVCR Insider Trading Activity - Frequently Asked Questions Who is on NovoCure's Insider Roster? The list of insiders at NovoCure includes Asaf Danziger, Ashley Cordova, Ely Benaim, Frank X Leonard, Jeryl L Hilleman, Michal Nath Puri, Mukund Paravasthu, Pritesh Shah, Uri Weinberg, W Anthony Vernon, Wilhelmus Cm Groenhuysen, and William F Doyle. Learn more on insiders at NVCR. What percentage of NovoCure stock is owned by insiders? 6.29% of NovoCure stock is owned by insiders. Learn more on NVCR's insider holdings. Which NovoCure insiders have been selling company stock? The following insiders have sold NVCR shares in the last 24 months: Ashley Cordova ($33,123.38), Frank X Leonard ($83,433.81), Michal Nath Puri ($12,789.90), Mukund Paravasthu ($2,540.80), Pritesh Shah ($10,789.16), W Anthony Vernon ($23,029.96), and Wilhelmus Cm Groenhuysen ($59,674.46). How much insider selling is happening at NovoCure? Insiders have sold a total of 12,973 NovoCure shares in the last 24 months for a total of $225,381.47 sold. NovoCure Key ExecutivesMr. William F. Doyle (Age 62)Executive Chairman Compensation: $1.43MMr. Asaf Danziger (Age 58)CEO & Director Compensation: $1.52MMs. Ashley Cordova (Age 45)Chief Financial Officer Compensation: $814.81kMr. Wilhelmus C. M. Groenhuysen (Age 66)Chief Operating Officer Compensation: $965.56kMr. Barak Ben Arye (Age 47)General Counsel Compensation: $761.97kMr. Frank LeonardExecutive VP & President of Novocure Oncology1 recent tradesProf. Yoram Palti M.D. (Age 86)Ph.D., Founder & CTO Compensation: $282.51kDr. Moshe Giladi Ph.D. (Age 54)Chief Science Officer Ms. Ingrid GoldbergVP of Investor RelationsMr. Michael Puri (Age 55)Chief Human Resources Officer More Insider Trading Tools from MarketBeat Related Companies GKOS Insider Transactions BLCO Insider Transactions INSP Insider Transactions NARI Insider Transactions IRTC Insider Transactions PRCT Insider Transactions NVST Insider Transactions TMDX Insider Transactions ENOV Insider Transactions SLNO Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish This page (NASDAQ:NVCR) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovoCure Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NovoCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVCR Stock Free NVCR Stock Alerts